Arbutus and Genevant Sue Moderna in First Significant Patent Infringement Lawsuit in the mRNA Space

March 27, 2022

Delaware Judge Denies Sarepta Protection Under Hatch-Waxman “Safe Harbor”

January 5, 2022

mRNA Patent and Competitive Landscape: 2021 Year in Review and 2022 Outlook

January 3, 2022

Three (3) Initial Considerations for Entrepreneurial Faculty, Researchers, Post-Docs, and Graduate Students

November 17, 2021

Alphabet Dives Further Into AI-Driven Drug Discovery

November 5, 2021

Next Up for BioNTech: Malaria

July 27, 2021

The mRNA Patent and Competitive Landscape: Pioneers, Litigation Outlook and Big Pharma’s Next Moves (Part III)

May 10, 2021

The mRNA Patent and Competitive Landscape: Translate BIO; Arcturus; eTheRNA and Other Startups; and LNP Technology (Part II)

May 2, 2021

The mRNA Patent and Competitive Landscape Through One Year of the COVID-19 Pandemic–Part I

April 12, 2021

IP Assignment Considerations for Emerging Companies

March 26, 2021